Literature DB >> 17190863

Hemodynamic modulation of endocardial thromboresistance.

Navin K Kapur1, Clayton B Deming, Sunil Kapur, Ce Bian, Hunter C Champion, J Kevin Donahue, David A Kass, Jeffrey J Rade.   

Abstract

BACKGROUND: Patients with heart failure are at increased risk for thromboembolic events, including stroke. Historically attributed to blood stasis, little is known about the adverse effects of elevated chamber filling pressure on endocardial function, which could predispose to intracardiac thrombus formation. METHODS AND
RESULTS: We investigated changes in the expression of thrombomodulin, a key component of the anticoagulant protein C pathway, in rats subjected to acute atrial pressure overload caused by aortic banding. Acute elevation of left atrial filling pressure, without an associated decline in ventricular systolic function, caused a 70% inhibition of atrial endocardial thrombomodulin expression and resulted in increased local thrombin generation. Targeted restoration of atrial thrombomodulin expression with adenovirus-mediated gene transfer successfully reduced thrombin generation to baseline levels. In vitro co-culture studies revealed that thrombomodulin downregulation is caused by the paracrine release of transforming growth factor-beta from cardiac connective tissue in response to mechanical stretch. This was confirmed in vivo by administration of a neutralizing transforming growth factor-beta antibody, which effectively prevented thrombomodulin downregulation during acute pressure overload.
CONCLUSIONS: These findings suggest that increased hemodynamic load adversely affects endocardial function and is a potentially important contributor to thromboembolus formation in heart failure.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17190863     DOI: 10.1161/CIRCULATIONAHA.106.640698

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  15 in total

1.  Reduced endoglin activity limits cardiac fibrosis and improves survival in heart failure.

Authors:  Navin K Kapur; Szuhuei Wilson; Adil A Yunis; Xiaoying Qiao; Emily Mackey; Vikram Paruchuri; Corey Baker; Mark J Aronovitz; S Ananth Karumanchi; Michelle Letarte; David A Kass; Michael E Mendelsohn; Richard H Karas
Journal:  Circulation       Date:  2012-05-16       Impact factor: 29.690

Review 2.  Pulling on my heartstrings: mechanotransduction in cardiac development and function.

Authors:  Margaret E McCormick; Ellie Tzima
Journal:  Curr Opin Hematol       Date:  2016-05       Impact factor: 3.284

Review 3.  Novel therapeutic targets for preserving a healthy endothelium: strategies for reducing the risk of vascular and cardiovascular disease.

Authors:  Joseph Ramli; Pedro CalderonArtero; Robert C Block; Shaker A Mousa
Journal:  Cardiol J       Date:  2011       Impact factor: 2.737

4.  Inhibition of transforming growth factor-β restores endothelial thromboresistance in vein grafts.

Authors:  Navin K Kapur; Ce Bian; Edward Lin; Clayton B Deming; Jason L Sperry; Baranda S Hansen; Nikolaos Kakouros; Jeffrey J Rade
Journal:  J Vasc Surg       Date:  2011-07-31       Impact factor: 4.268

Review 5.  Biological Therapies for Atrial Fibrillation: Ready for Prime Time?

Authors:  J Kevin Donahue
Journal:  J Cardiovasc Pharmacol       Date:  2016-01       Impact factor: 3.105

Review 6.  Gene Therapy for Cardiac Arrhythmias.

Authors:  Tetsuo Sasano; Kentaro Takahashi; Koji Sugiyama
Journal:  Acta Cardiol Sin       Date:  2013-05       Impact factor: 2.672

7.  Bone Morphogenetic Protein 9 Reduces Cardiac Fibrosis and Improves Cardiac Function in Heart Failure.

Authors:  Kevin J Morine; Xiaoying Qiao; Sam York; Peter S Natov; Vikram Paruchuri; Yali Zhang; Mark J Aronovitz; Richard H Karas; Navin K Kapur
Journal:  Circulation       Date:  2018-07-31       Impact factor: 29.690

8.  Left Ventricular Unloading Before Reperfusion Promotes Functional Recovery After Acute Myocardial Infarction.

Authors:  Michele L Esposito; Yali Zhang; Xiaoying Qiao; Lara Reyelt; Vikram Paruchuri; Gavin R Schnitzler; Kevin J Morine; Shiva K Annamalai; Courtney Bogins; Peter S Natov; Robert Pedicini; Catalina Breton; Andrew Mullin; Emily E Mackey; Ayan Patel; Ethan Rowin; Iris Z Jaffe; Richard H Karas; Navin K Kapur
Journal:  J Am Coll Cardiol       Date:  2018-07-31       Impact factor: 24.094

9.  Genetic modifiers of hypertension in soluble guanylate cyclase α1-deficient mice.

Authors:  Emmanuel S Buys; Michael J Raher; Andrew Kirby; Mohd Shahid; Shahid Mohd; David M Baron; Sarah R Hayton; Laurel T Tainsh; Patrick Y Sips; Kristen M Rauwerdink; Qingshang Yan; Robert E T Tainsh; Hannah R Shakartzi; Christine Stevens; Kelly Decaluwé; Maria da Gloria Rodrigues-Machado; Rajeev Malhotra; Johan Van de Voorde; Tong Wang; Peter Brouckaert; Mark J Daly; Kenneth D Bloch
Journal:  J Clin Invest       Date:  2012-05-08       Impact factor: 14.808

10.  Cyclic stretch induces cyclooxygenase-2 gene expression in vascular endothelial cells via activation of nuclear factor kappa-beta.

Authors:  Haige Zhao; Toyoko Hiroi; Baranda S Hansen; Jeffrey J Rade
Journal:  Biochem Biophys Res Commun       Date:  2009-09-11       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.